Surveillance for Colorectal Neoplasia in Inflammatory Bowel Disease: When to Stop

被引:1
|
作者
Axelrad, Jordan E. [1 ]
Cross, Raymond K. [2 ]
机构
[1] NYU, Grossman Sch Med, Dept Med, Div Gastroenterol, New York, NY 10012 USA
[2] Univ Maryland, Dept Med, Div Gastroenterol & Hepatol, Sch Med, Baltimore, MD USA
来源
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 118卷 / 03期
关键词
colorectal neoplasia; dysplasia; colorectal cancer; inflammatory bowel disease; ulcerative colitis; Crohn's disease; colonoscopy; EVIDENCE-BASED CONSENSUS; ULCERATIVE-COLITIS; AMERICAN-COLLEGE; CANCER-RISK; DYSPLASIA; GUIDELINES; MANAGEMENT; ENDOSCOPY; UPDATE; METAANALYSIS;
D O I
10.14309/ajg.0000000000002168
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Patients with chronic ulcerative and Crohn's colitis are at increased risk for colorectal neoplasia(CRN [dysplasia and cancer]) compared to the general population. Risk factors for CRN include extent of colitis, cumulative inflammatory burden, family history of colorectal cancer, and primary sclerosing cholangitis. Best practices to prevent CRN include control of colonic inflammation, high quality surveillance colonoscopy with or without enhanced imaging techniques, resection of visible dysplasia if possible, and colectomy in patients with unresectable dysplasia, invisible multifocal low grade dysplasia, or invisible high grade dysplasia. Cessation of dysplasia surveillance is individualized and should involve shared decision making based on factors including but not limited to chronologic age, frailty, co-morbid conditions, life expectancy, results of prior surveillance exams, and risk factors for CRN.
引用
收藏
页码:429 / 431
页数:3
相关论文
共 50 条
  • [21] Colorectal cancer surveillance in inflammatory bowel disease: The search continues
    Anis Ahmadi
    Steven Polyak
    Peter V Draganov
    World Journal of Gastroenterology, 2009, 15 (01) : 61 - 66
  • [22] Chromoendoscopy for Colorectal Cancer Surveillance in Patients with Inflammatory Bowel Disease
    Shah S.A.
    Rubin D.T.
    Farraye F.A.
    Current Gastroenterology Reports, 2014, 16 (9)
  • [23] Individualised surveillance strategies for colorectal cancer in inflammatory bowel disease
    Baars, Judith E.
    Looman, Caspar W. N.
    Steyerberg, Ewout W.
    Kuipers, Ernst J.
    van der Woude, Christien J.
    GUT, 2011, 60 (05) : 739 - 739
  • [24] Colorectal cancer surveillance in inflammatory bowel disease: The search continues
    Ahmadi, Anis
    Polyak, Steven
    Draganciv, Peter V.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (01) : 61 - 66
  • [25] Colorectal Cancer in Inflammatory Bowel Disease: Epidemiology, Pathogenesis and Surveillance
    Wang, Zhen-Hua
    Fang, Jing-Yuan
    GASTROINTESTINAL TUMORS, 2014, 1 (03) : 146 - 154
  • [26] Improving detection of colorectal dysplasia in inflammatory bowel disease surveillance
    Kaltenbach, Tonya
    McQuaid, Kenneth R.
    Soetikno, Roy
    Laine, Loren
    GASTROINTESTINAL ENDOSCOPY, 2016, 83 (05) : 1013 - 1014
  • [27] Colorectal cancer surveillance in inflammatory bowel disease: A critical analysis
    Desai, Devendra
    Desai, Nutan
    WORLD JOURNAL OF GASTROINTESTINAL ENDOSCOPY, 2014, 6 (11): : 541 - 548
  • [28] Thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease
    van Schaik, Fiona D. M.
    van Oijen, Martijn G. H.
    Smeets, Hugo M.
    van der Heijden, Geert J. M. G.
    Siersema, Peter D.
    Oldenburg, Bas
    GUT, 2012, 61 (02) : 235 - 240
  • [29] Considerations for Colorectal Neoplasia Detection in Inflammatory Bowel Disease Clinical Trials
    Yang, Mira M.
    Usiskin, Keith
    Ahmad, Harris A.
    Ather, Shabana
    Sreih, Antoine
    Canavan, James B.
    Farraye, Francis A.
    Ma, Christopher
    DIGESTIVE DISEASES, 2024, 42 (01) : 12 - 24
  • [30] CIGARETTE SMOKE INCREASES RISK FOR COLORECTAL NEOPLASIA IN INFLAMMATORY BOWEL DISEASE
    Van der Sloot, Kimberley
    Tiems, Johan
    Visschedijk, Marijn
    Festen, Eleonora
    van Dullemen, Hendrik
    Weersma, Rinse
    Kats-Ugurlu, Gursah
    Dijkstra, Gerard
    GASTROENTEROLOGY, 2021, 160 (03) : S19 - S19